PharmaEngine, Inc. (TPEX:4162)
Taiwan
· Delayed Price · Currency is TWD 98.80
+1.50 (1.54%)
Apr 2, 2025, 1:30 PM CST
PharmaEngine Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 993.7 | 875.62 | 1,769 | 2,151 | 1,836 | Upgrade
|
| Short-Term Investments | 2,867 | 2,752 | 1,837 | 1,663 | 1,558 | Upgrade
|
| Trading Asset Securities | - | - | 55.59 | - | - | Upgrade
|
| Cash & Short-Term Investments | 3,861 | 3,628 | 3,661 | 3,814 | 3,394 | Upgrade
|
| Cash Growth | 6.42% | -0.91% | -4.00% | 12.37% | -0.64% | Upgrade
|
| Accounts Receivable | 1,844 | 174.17 | 160.34 | 160.48 | 644.52 | Upgrade
|
| Other Receivables | 87.59 | 97.41 | 63.51 | 22.83 | 95.81 | Upgrade
|
| Receivables | 1,932 | 271.58 | 223.85 | 183.31 | 740.33 | Upgrade
|
| Inventory | 28.38 | 15.9 | 34.38 | 5.43 | 24.74 | Upgrade
|
| Prepaid Expenses | 6.4 | 7.48 | 6.57 | 6.48 | 10.56 | Upgrade
|
| Other Current Assets | - | - | - | 0.08 | 0.48 | Upgrade
|
| Total Current Assets | 5,827 | 3,923 | 3,926 | 4,009 | 4,170 | Upgrade
|
| Property, Plant & Equipment | 10.24 | 18.03 | 25.92 | 7.89 | 22.95 | Upgrade
|
| Other Intangible Assets | 1.78 | 1.88 | 2.51 | 0.6 | 0.83 | Upgrade
|
| Long-Term Deferred Tax Assets | 5.91 | 8 | 9.54 | 4.98 | 6.84 | Upgrade
|
| Other Long-Term Assets | 2.44 | 2.98 | 2.5 | 3.9 | 6.44 | Upgrade
|
| Total Assets | 5,848 | 3,954 | 3,967 | 4,026 | 4,207 | Upgrade
|
| Accrued Expenses | 99.31 | 67.22 | 61.31 | 64.14 | 48.22 | Upgrade
|
| Current Portion of Leases | 7.14 | 7.67 | 7.54 | 7.59 | 10.77 | Upgrade
|
| Current Income Taxes Payable | 327.9 | - | - | 6.92 | 34.69 | Upgrade
|
| Other Current Liabilities | 8.7 | 8.98 | 9.9 | 9.06 | 90.78 | Upgrade
|
| Total Current Liabilities | 443.05 | 83.86 | 78.74 | 87.71 | 184.46 | Upgrade
|
| Long-Term Leases | - | 7.14 | 14.81 | - | 11.31 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 4.96 | - | 0.92 | - | 0 | Upgrade
|
| Total Liabilities | 448.01 | 91.01 | 94.47 | 87.71 | 195.78 | Upgrade
|
| Common Stock | 1,457 | 1,457 | 1,457 | 1,466 | 1,466 | Upgrade
|
| Additional Paid-In Capital | 1,616 | 1,616 | 1,617 | 1,620 | 1,620 | Upgrade
|
| Retained Earnings | 2,461 | 925.31 | 937.85 | 1,101 | 1,039 | Upgrade
|
| Treasury Stock | -133.41 | -133.41 | -133.41 | -248.24 | -114.83 | Upgrade
|
| Comprehensive Income & Other | -0.41 | -1.79 | -5.97 | - | 1.21 | Upgrade
|
| Shareholders' Equity | 5,400 | 3,863 | 3,872 | 3,939 | 4,011 | Upgrade
|
| Total Liabilities & Equity | 5,848 | 3,954 | 3,967 | 4,026 | 4,207 | Upgrade
|
| Total Debt | 7.14 | 14.81 | 22.35 | 7.59 | 22.08 | Upgrade
|
| Net Cash (Debt) | 3,854 | 3,613 | 3,639 | 3,806 | 3,372 | Upgrade
|
| Net Cash Growth | 6.65% | -0.71% | -4.39% | 12.88% | -0.33% | Upgrade
|
| Net Cash Per Share | 26.78 | 25.14 | 25.32 | 26.30 | 23.11 | Upgrade
|
| Filing Date Shares Outstanding | 143.68 | 143.68 | 143.69 | 143.6 | 145.6 | Upgrade
|
| Total Common Shares Outstanding | 143.68 | 143.68 | 143.69 | 143.6 | 145.6 | Upgrade
|
| Working Capital | 5,384 | 3,839 | 3,847 | 3,921 | 3,985 | Upgrade
|
| Book Value Per Share | 37.58 | 26.89 | 26.95 | 27.43 | 27.55 | Upgrade
|
| Tangible Book Value | 5,398 | 3,861 | 3,870 | 3,938 | 4,010 | Upgrade
|
| Tangible Book Value Per Share | 37.57 | 26.87 | 26.93 | 27.42 | 27.54 | Upgrade
|
| Machinery | 5.18 | 4.44 | 4.03 | 0.8 | 4.97 | Upgrade
|
| Leasehold Improvements | - | 7.69 | 7.69 | 7.69 | 9.61 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.